Table 3 The BP and BD responses to sulforaphane treatment, classified according to initial increased or decreased forced expiratory volume in 1-second (FEV₁) response to MCh (mean ± SD). Wilcoxon sign rank test

Overall FEV₁ (from Table 2)

15.5 ± 52.7

10.3 ± 57

0.82

32.5 ± 32.7

28.2 ± 28

0.33

Decreased FEV₁ response to MCh (n = 29)

37.6 ± 38.0

−0.8 ± 64

0.002

38.3 ± 34.6

23.2 ± 35.1

0.02

Increased FEV₁ response to MCh (n = 15)

−27.2 ± 51.7

31.7 ± 33

0.004

19.6 ± 25.1

33.4 ± 18.6

0.04